Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine and Rosuvastatin for Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer
NCT07504198Phase 3Not yet recruiting
- Sponsor
- Tanta University
- Start
- Mar 2026
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of memantine, rosuvastatin in peripheral neuropathy, sponsored by Tanta University. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
memantinerosuvastatin
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT07504198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07504198.